Research Study

Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Previous Intracerebral Hemorrhage Study
Principal Investigator 
Thalia Field

Overview

Body Locations and Systems 
ClinicalTrials.gov# 
NCT02998905
Status 
Recruiting
Study Start/End 
Nov 17, 2017 to Jan 31, 2020
Locations 
Diamond Health Care Centre, Vancouver General Hospital
Name/Title 
Karina Villaluna Murray, Clinical Research Coordinator
Phone 
604-875-4554 ext.1
Purpose of Study 

To determine the feasibility of a controlled trial examining the efficacy and safety of non-vitamin K antagonist oral anticoagulants (NOACs) compared with ASA for stroke prevention in patients with a high-risk of atrial fibrillation and previous intracerebral hemorrhage.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.